• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

塑造细胞毒性T淋巴细胞反应库:对免疫显性效应的解释,即针对免疫显性抗原的细胞毒性T淋巴细胞会阻止对非显性抗原的识别。

Shaping the repertoire of cytotoxic T-lymphocyte responses: explanation for the immunodominance effect whereby cytotoxic T lymphocytes specific for immunodominant antigens prevent recognition of nondominant antigens.

作者信息

Pion S, Christianson G J, Fontaine P, Roopenian D C, Perreault C

机构信息

Research Center, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada; and The Jackson Laboratory, Bar Harbor, ME, USA.

出版信息

Blood. 1999 Feb 1;93(3):952-62.

PMID:9920845
Abstract

The immunodominance effect, whereby the presence of immunodominant epitopes prevents recognition of nondominant determinants presented on the same antigen-presenting cell (APC) considerably restricts the repertoire of cytotoxic T lymphocyte (CTL) responses. To elucidate the molecular basis of the immunodominance effect, we compared the interactions of a dominant (B6(dom1)) and a nondominant epitope (H-Y) with their restricting class I molecule (H2-Db), and their ability to trigger cognate CTLs. We found that B6(dom1)/Db complexes behaved as optimal T-cell receptor (TCR) ligands and triggered a more rapid in vivo expansion of cognate CTLs than H-Y/Db complexes. The superiority of the dominant epitope was explained by its high cell surface density (1,012 copies/cell for B6(dom1) v 10 copies/cell for H-Y) and its optimal affinity for cognate TCRs. Based on these results, we conclude that dominant class I-associated epitopes are those that have optimal ability to trigger TCR signals in CTLs. We propose that the rapid expansion of CTLs specific for dominant antigens should enable them to compete more successfully than other CTLs for occupancy of the APC surface.

摘要

免疫显性效应,即免疫显性表位的存在会阻止对同一抗原呈递细胞(APC)上呈递的非显性决定簇的识别,这在很大程度上限制了细胞毒性T淋巴细胞(CTL)反应的库。为了阐明免疫显性效应的分子基础,我们比较了一个显性表位(B6(dom1))和一个非显性表位(H-Y)与其限制性I类分子(H2-Db)的相互作用,以及它们触发同源CTL的能力。我们发现,B6(dom1)/Db复合物表现为最佳的T细胞受体(TCR)配体,并且比H-Y/Db复合物在体内触发同源CTL的扩增更快。显性表位的优势在于其高细胞表面密度(B6(dom1)为1012个拷贝/细胞,而H-Y为10个拷贝/细胞)以及对同源TCR的最佳亲和力。基于这些结果,我们得出结论,显性I类相关表位是那些在CTL中具有最佳触发TCR信号能力的表位。我们提出,针对显性抗原的CTL的快速扩增应使它们比其他CTL更成功地竞争占据APC表面。

相似文献

1
Shaping the repertoire of cytotoxic T-lymphocyte responses: explanation for the immunodominance effect whereby cytotoxic T lymphocytes specific for immunodominant antigens prevent recognition of nondominant antigens.塑造细胞毒性T淋巴细胞反应库:对免疫显性效应的解释,即针对免疫显性抗原的细胞毒性T淋巴细胞会阻止对非显性抗原的识别。
Blood. 1999 Feb 1;93(3):952-62.
2
On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens.关于细胞毒性T淋巴细胞对次要组织相容性抗原反应中免疫显性的机制
Eur J Immunol. 1997 Feb;27(2):421-30. doi: 10.1002/eji.1830270212.
3
Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes.针对次要组织相容性抗原的细胞毒性T淋巴细胞反应中的免疫显性:反应性T细胞之间的干扰,而非表位呈递的干扰。
J Immunol. 1998 Nov 1;161(9):4499-505.
4
Avidity of CD8 T cells sharpens immunodominance.CD8 T细胞的亲和力增强免疫显性。
Int Immunol. 2007 Apr;19(4):497-507. doi: 10.1093/intimm/dxm016. Epub 2007 Mar 21.
5
Immunodominant minor histocompatibility antigen peptides presented by H2Db molecules.由H2Db分子呈递的免疫显性次要组织相容性抗原肽。
Transplantation. 1997 Nov 15;64(9):1323-30. doi: 10.1097/00007890-199711150-00015.
6
Immunodomination results from functional differences between competing CTL.免疫显性源于相互竞争的细胞毒性T淋巴细胞(CTL)之间的功能差异。
Eur J Immunol. 2001 Aug;31(8):2284-92. doi: 10.1002/1521-4141(200108)31:8<2284::aid-immu2284>3.0.co;2-e.
7
Contemporary analysis of MHC-related immunodominance hierarchies in the CD8+ T cell response to influenza A viruses.甲型流感病毒CD8+ T细胞应答中与主要组织相容性复合体(MHC)相关的免疫显性等级的当代分析。
J Immunol. 2000 Sep 1;165(5):2404-9. doi: 10.4049/jimmunol.165.5.2404.
8
Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype.用腺病毒载体多次免疫后,针对免疫隐性表位产生细胞毒性T淋巴细胞取决于单倍型。
J Virol. 1997 Mar;71(3):2277-84. doi: 10.1128/JVI.71.3.2277-2284.1997.
9
Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice.细胞毒性T淋巴细胞表位免疫显性在猿猴病毒40大T抗原转基因小鼠脉络丛肿瘤控制中的作用
J Virol. 1999 Jul;73(7):5981-93. doi: 10.1128/JVI.73.7.5981-5993.1999.
10
The in vivo fate of APCs displaying minor H antigen and/or MHC differences is regulated by CTLs specific for immunodominant class I-associated epitopes.展示次要组织相容性抗原和/或主要组织相容性复合体差异的抗原呈递细胞的体内命运,由针对免疫显性的I类相关表位的细胞毒性T淋巴细胞调控。
J Immunol. 1999 Dec 15;163(12):6462-7.

引用本文的文献

1
Deletion of naïve T cells recognizing the minor histocompatibility antigen HY with toxin-coupled peptide-MHC class I tetramers inhibits cognate CTL responses and alters immunodominance.用毒素偶联肽-MHC Ⅰ类四聚体删除识别次要组织相容性抗原 HY 的幼稚 T 细胞可抑制同源 CTL 反应并改变免疫优势。
Transpl Immunol. 2013 Dec;29(1-4):138-45. doi: 10.1016/j.trim.2013.10.005. Epub 2013 Oct 23.
2
Broadening of the T-cell repertoire to HIV-1 Gag p24 by vaccination of HLA-A2/DR transgenic mice with overlapping peptides in the CAF05 adjuvant.用 CAF05 佐剂进行重叠肽疫苗接种,拓宽 HLA-A2/DR 转基因小鼠针对 HIV-1 Gag p24 的 T 细胞 repertoire。
PLoS One. 2013 May 17;8(5):e63575. doi: 10.1371/journal.pone.0063575. Print 2013.
3
Increasing the efficacy of tumor cell vaccines by enhancing cross priming.通过增强交叉呈递来提高肿瘤细胞疫苗的疗效。
Cancer Lett. 2012 Dec 28;325(2):155-64. doi: 10.1016/j.canlet.2012.07.012. Epub 2012 Jul 16.
4
Tumor-derived autophagosome vaccine: induction of cross-protective immune responses against short-lived proteins through a p62-dependent mechanism.肿瘤来源的自噬体疫苗:通过 p62 依赖性机制诱导针对短寿命蛋白的交叉保护免疫应答。
Clin Cancer Res. 2011 Oct 15;17(20):6467-81. doi: 10.1158/1078-0432.CCR-11-0812. Epub 2011 Aug 2.
5
Direct presentation regulates the magnitude of the CD8+ T cell response to cell-associated antigen through prolonged T cell proliferation.直接呈递通过延长 T 细胞增殖来调节细胞相关抗原的 CD8+T 细胞反应的幅度。
J Immunol. 2010 Sep 1;185(5):2763-72. doi: 10.4049/jimmunol.0903920. Epub 2010 Jul 26.
6
Portable flanking sequences modulate CTL epitope processing.可移植侧翼序列调节细胞毒性T淋巴细胞表位加工。
J Clin Invest. 2007 Nov;117(11):3563-75. doi: 10.1172/JCI32047.
7
Differential outcome of tolerance induction in naive versus activated Theiler's virus epitope-specific CD8+ cytotoxic T cells.初始与活化的泰勒氏病毒表位特异性CD8 + 细胞毒性T细胞在耐受性诱导中的不同结果。
J Virol. 2007 Jun;81(12):6584-93. doi: 10.1128/JVI.00008-07. Epub 2007 Apr 11.
8
RNA-transfected dendritic cells in cancer immunotherapy.癌症免疫治疗中经RNA转染的树突状细胞
J Clin Invest. 2000 Nov;106(9):1065-9. doi: 10.1172/JCI11405.